Impact Factor
3.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.42
1,430 total citations
h5-index
41
h5 depth signal
Cited share
58.0%
255 of 440
Total citations
1,430
Citation footprint
Metric signal
3.10
External metric anchor
Self-citation
3.2%
46 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
488
China
335
Germany
239
Australia
171
United Kingdom
110
Citing Fields of Research
Mass Spectrometry
830
Genetics & Genomics
285
Cell Biology
276
Noncoding RNA
131
Bacteriology
125
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
9,518
Articles tracked across the journal lifetime
Indexed publication set
440
255 cited publications
Last 12 months
136
11.3 publications/month
Open access share
45.6%
62 OA publications in the last year
Leading citing country
United States
488 citing publications
Leading citing field
Mass Spectrometry
830 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan. 2001-
v1n1, Jan. 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Mass Spectrometry
Broad Categories
Biochemistry
Mass Spectrometry
MeSH Descriptors
Genome
Proteins
Proteome
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1002/pmic.70197
Open DOI
Integrated Multiomics Profiling Reveals Membrane‐Associated Signaling Alterations Associated With Disease Activity in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by pervasive immune dysregulation, yet membrane‐associated molecular alterations in immune cells remain incompletely defined. Here, we performed integrated ...
03
DOI 10.1002/pmic.70196
Open DOI
Advancing Cancer Biomarker Discovery Through Multi‐Omics, Bioinformatics, and Artificial Intelligence: A Systematic Review
The rapid accumulation of multi‐omics data provides increasing opportunities for cancer biomarker discovery, but the heterogeneity and high dimensionality of these datasets remain major challenges for data integration and analysis. This ...
04
DOI 10.1002/pmic.70195
Open DOI
Comparative Proteomic Quantification Reveals Novel Longevity Regulators
Proteomics is a powerful tool for profiling the protein landscape underlying cellular and physiological processes. Advances in mass spectrometry‐based methods, such as tandem mass tags (TMT) isobaric labeling‐based proteomics at both MS2...
05
06
07
08
09
DOI 10.1002/pmic.70189
Open DOI
Proteomic Analysis of Mixed Cell Membrane Extracts From Triple‐Negative Breast Cancer Cell Lines Revealed Broad Metabolic Reprogramming Associated With Tumor Progression
Triple‐negative breast cancer (TNBC) represents the most aggressive subtype with limited therapeutic options and the poorest clinical outcomes. Using high‐resolution nUPLC‐QTOF‐MS/MS, we performed comprehensive proteomic profiling of TNB...
10
DOI 10.1002/pmic.70190
Open DOI
Bead‐Based Enrichment Methods for Unbiased Secretome Profiling Enable Unprecedented Protein Coverage in an Immune Cell Model
Bead‐based enrichment strategies for low‐abundance proteins in biofluids, followed by LC‐MS/MS analysis, have dramatically increased the coverage of the serum and plasma proteome. These technologies effectively mitigate the dynamic range...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 3 (Mar. 2001); title from cover.
Some issues consist of proceedings of various conferences.
Some issues have also distinctive titles.
Also issued online.
v. 1, no. 1 (Jan. 2001)20010730 Notice published Printed on acid-free paper